This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Lixia Luo: Innovator in Corneal Allograft Rejection Prevention
Introduction
Lixia Luo is a prominent inventor based in Province, CN. She has made significant contributions to the field of biomedical engineering, particularly in the area of corneal transplantation. Her innovative work focuses on developing advanced solutions to prevent corneal allograft rejection and neovascularization.
Latest Patents
Lixia Luo holds 1 patent for her invention titled "Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization." This patent describes particles that encapsulate a glucocorticoid, such as dexamethasone sodium phosphate (DSP), into a matrix made of biodegradable poly(lactic-coglycolic acid) (PLGA). These particles are densely coated with hydrophilic polymers like PEG or PLURONIC® F127, allowing for the sustained release of DSP for up to 7 days in vitro. This innovative approach aims to prevent corneal graft rejection and neovascularization effectively.
Career Highlights
Lixia Luo is affiliated with Johns Hopkins University, where she continues her research and development in the field of ocular health. Her work has garnered attention for its potential to improve patient outcomes in corneal transplantation.
Collaborations
Lixia has collaborated with notable colleagues, including Qing Pan and Nicholas J Boylan, to advance her research initiatives. Their combined expertise contributes to the innovative solutions being developed in her field.
Conclusion
Lixia Luo's contributions to the field of corneal transplantation through her innovative patent demonstrate her commitment to improving medical outcomes. Her work exemplifies the impact of research and innovation in addressing critical health challenges.